Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05749250

Ultrasound Cavitation Therapy for CLI

Led by University of Virginia · Updated on 2023-03-01

30

Participants Needed

1

Research Sites

129 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

In this study, we will explore how ultrasound exposure of ultrasound contrast agents, which produces beneficial shear-mediated bioeffects, can be used to treat patients with severe non-healing ulcers secondary to peripheral arterial disease (PAD). The primary outcome measure is whether ultrasound exposure to microbubble contrast agents in the inflow artery and at the wound site can accelerate wound healing. A secondary outcome measure is whether cavitation-related changes occur in tissue perfusion in the treated limb and wound measured by ultrasound perfusion imaging and skin flow.

CONDITIONS

Official Title

Ultrasound Cavitation Therapy for CLI

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Known history of unilateral or bilateral peripheral arterial disease diagnosed by reduced ankle-brachial index (<0.9) or non-compressible vessels
  • Diagnosis of critical limb ischemia (Rutherford class IV-VI)
  • Presence of a non-healing ischemic ulcer with no change in the prior 3 months
Not Eligible

You will not qualify if you...

  • Major medical illness other than peripheral arterial disease affecting the limb (muscle disease, blood diseases that influence flow or rheology, severe heart failure [NYHA class IV])
  • Pregnant or lactating females
  • Hypersensitivity to any ultrasound contrast agent or to polyethylene glycol (PEG, macrogol)
  • Hemodynamic instability (hypotension with systolic blood pressure <90 mm Hg or need for vasopressors)
  • Expected amputation or revascularization procedure within the next 1 month

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Virginia

Charlottesville, Virginia, United States, 22908

Actively Recruiting

Loading map...

Research Team

J

Jonathan Lindner, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here